Interventional radiology preparedness during coronavirus disease (COVID-19) pandemic

Garg, Tushar; Desai, Ajinkya; Gala, Kunal; Warawdekar, Gireesh; Tavri, Sidhartha

doi:10.4103/ijri.ijri_442_20

Cited by 2 publications

(5 citation statements)

References 21 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(18)(19)(20). During the pandemic process, increased emergency patient burden IR were observed in our center, whether infected or not, when compared to the previous year (17).…”

Section: Discussionmentioning

confidence: 65%

“…Strategies were developed to decrease infection risks. Unnecessary aerosolgenerating procedures were avoided as much as possible to protect healthcare employees (3,(17)(18)(19)(20)22). AC is an acute in ammatory disease of the GB requiring immediate treatment.…”

Section: Discussionmentioning

confidence: 99%

“…The median value for the duration of hospital stay was found to be 3 (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18) days in the prepandemic period, and 3(1-30) days in the pandemic period, and no statistically signi cant differences were detected between the groups (p = 0.794) (Table 2).…”

Section: The Comparison Of Pandemic and Prepandemic Groups And Evalua...mentioning

confidence: 96%

“…Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions? Percutaneous Cholecystostomy (PC) is the alternative treatment option in patients who cannot undergo surgery because of the higher AC prevalence and the mortality of COVID-19 with morbidity in elderly patients, increased number of patients during the pandemic period, and the occupancy of Intensive Care Units (ICU) (1,6,7,17, 21,22). The purpose of the present study was to show that PC therapy is safe and effective both for patients and for healthcare professionals who perform the procedure, in patients with AC, which can be seen at any age before and during the COVID-19 pandemic.…”

mentioning

confidence: 99%

See 3 more Smart Citations

The efficacy of percutaneous cholecystostomy in patients with acute cholecystitis before and during the COVID-19 pandemic. Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions?

Topal

Sönmez

Dağistanlı

2022

Preprint

View full text Add to dashboard Cite

Purposes: The purpose of the present paper was to prove the efficacy of Percutaneous Cholecystostomy (PC) in the treatment of patients with Acute Cholecystitis (AC) before the COVID-19 pandemic and especially during the pandemic, and to show that it is a safe procedure for patients and healthcare professionals.Materials and Methods: The demographic data of the patients with AC who applied to our hospital, who underwent PC procedure in the 24-month and 12-month period before and during the pandemic, clinical and laboratory data, technical success of PC, clinical response to treatment, length of hospital stay, one-month postprocedural observation, and complications were compared.Results: PC was applied to a total of 124 patients in the pre-pandemic period (52) and pandemic period (72) examined in the study. The median age was 73.5 (25–93) in the pre-pandemic period, and 64 (23–90) in the pandemic period, and the difference between these was found to be significant (p = 0.004). Clinical improvement due to PC was detected in 43 (86%) patients in the pre-pandemic period, and in 61 (84.7%) patients in the pandemic period, no significant differences were detected between the two groups (p = 1.000). The day of hospitalization median value was 3 (1–18) days in pandemic period, and 3 (1–30) days in the pandemic period, and no significant differences were detected between the groups (p = 0.794).ConclusionPC treatment in patients with AC during the pandemic andpre-pandemicc period is effective and safe for both the patient and the healthcare professionals who perform the procedure.The efficacy of percutaneous cholecystostomy in patients with acute cholecystitis before and during the COVID-19 pandemic. Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions?

show abstract

“…(18)(19)(20). During the pandemic process, increased emergency patient burden IR were observed in our center, whether infected or not, when compared to the previous year (17).…”

Section: Discussionmentioning

confidence: 65%

Section: Discussionmentioning

confidence: 99%

Section: The Comparison Of Pandemic and Prepandemic Groups And Evalua...mentioning

confidence: 96%

mentioning

confidence: 99%

See 2 more Smart Citations

The efficacy of percutaneous cholecystostomy in patients with acute cholecystitis before and during the COVID-19 pandemic. Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions?

Topal

Sönmez

Dağistanlı

2022

Preprint

View full text Add to dashboard Cite

show abstract

“…If patients had a positive PCR test or suspected Covid-19 on thorax CT, the PC procedures were performed considering the guidelines created for the prevention of Covid-19 for IR (Interventional Radiology) units. [25] Before the patient entered the IR room, proper coordination was established between the staff in the isolation room and the IR in charge so that there were no patients or relatives in the adjacent hallways.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous cholecystostomy in the management of acute cholecystitis-comparative analysis of before and after the COVID 19 pandemic

Kılınç

2023

Ulus Travma Acil Cerrahi Derg

View full text Add to dashboard Cite

BACKGROUND: Percutaneous cholecystostomy (PC) is a minimally invasive temporary treatment for patients with acute cholecystitis (AC) who are at high risk for surgery. The aim of this study was to compare the characteristics of patients with AC treated with PC before and during the coronavirus disease 2019 (COVID 19) pandemic. METHODS:The data of patients who underwent PC with the diagnosis of AC between 2019 and 2021 were analyzed by scanning the hospital registry system. During the COVID 19 pandemic period of March 11, 2020, to March 11, 2021 patients with AC were treated with PC. In the pre-pandemic period of March 2019 to March 2020, 99 patients who underwent PC were added to the study as a control group. The data of the 209 patients included in the study were recorded, and descriptive statistical analysis was performed. The patient characteristics of the two groups were compared. RESULTS:Evaluation was made of 209 patients who were diagnosed with AC between March 2019 and March 2021 and could not be operated on due to the high risk of surgery. The average age of the patients was 63.84 years (21-97) in the pandemic period and 68.43 years (31-100) in the pre-pandemic period. The rate of female patients was 45.5% in the pandemic group and 44.5% in the prepandemic group. The mean procedure-discharge time was 3.85 days in the pandemic period and 3.34 days pre-pandemic. The American Society of Anesthesiologists physical status classification (PS) was determined to be 1 or 2 in 56.4% of the pandemic group patients and 3 or 4 in 78.8% of the pre-pandemic group. There was no comorbidity accompanying AC in 45 (40.9%) patients in the pandemic period, and at least one comorbid condition accompanying AC was detected in 77 (77.8%) patients in the pre-pandemic period. The severity grading for AC was 2 (moderate) in 97.3% of the patients in the pandemic group and 3 (severe) in 26.3% of the patients in the pre-pandemic group. Of the 110 patients in the pandemic period, 14 were Covid 19 positive or suspected. PC-related mortality was not observed in either group. CONCLUSION:PC is an effective and safe treatment method that reduced the operating room and intensive care burden during the exacerbation of the COVID 19 pandemic. Therefore, it seems like a logical option to expand the PC indications at times when the number of COVID 19 patients increases.

show abstract

Interventional radiology preparedness during coronavirus disease (COVID-19) pandemic

Cited by 2 publications

References 21 publications

The efficacy of percutaneous cholecystostomy in patients with acute cholecystitis before and during the COVID-19 pandemic. Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions?

The efficacy of percutaneous cholecystostomy in patients with acute cholecystitis before and during the COVID-19 pandemic. Is the percutaneous cholecystostomy procedure safe for patients and healthcare professionals in pandemic conditions?

Percutaneous cholecystostomy in the management of acute cholecystitis-comparative analysis of before and after the COVID 19 pandemic

Contact Info

Product

Resources

About